13F
中

INCY INCYTE CORP

2026Q1 · CUSIP 45337C102 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price
Holders
804
Δ holders QoQ
-11
Breadth percentile
Top 87%
Whale holders
278
Δ whales
-7
Inst. holding value
$18.9B
New positions
109
Closed positions
120
Price momentum (1Q)
-5.9%
Put / Call
10/15

Breadth history (34 quarters)

2018Q1: Δ-2 · h=494 2018Q2: Δ-50 · h=444 2018Q3: Δ+8 · h=452 2018Q4: Δ-7 · h=445 2019Q1: Δ+61 · h=506 2019Q2: Δ-5 · h=501 2019Q3: Δ-12 · h=489 2019Q4: Δ+56 · h=545 2020Q1: Δ-62 · h=483 2020Q2: Δ+3 · h=486 2020Q3: Δ+5 · h=491 2020Q4: Δ+11 · h=502 2021Q1: Δ-19 · h=483 2021Q2: Δ+32 · h=515 2021Q3: Δ-27 · h=488 2021Q4: Δ+32 · h=520 2022Q1: Δ+7 · h=527 2022Q2: Δ+5 · h=532 2022Q3: Δ+0 · h=532 2022Q4: Δ+24 · h=556 2023Q1: Δ-4 · h=552 2023Q2: Δ-27 · h=525 2023Q3: Δ+1 · h=526 2023Q4: Δ+31 · h=557 2024Q1: Δ+25 · h=582 2024Q2: Δ+0 · h=582 2024Q3: Δ+8 · h=590 2024Q4: Δ+57 · h=647 2025Q1: Δ-16 · h=631 2025Q2: Δ+24 · h=655 2025Q3: Δ+55 · h=710 2025Q4: Δ+105 · h=815 2026Q1: Δ-11 · h=804 2018Q1: holders=494 2018Q2: holders=444 2018Q3: holders=452 2018Q4: holders=445 2019Q1: holders=506 2019Q2: holders=501 2019Q3: holders=489 2019Q4: holders=545 2020Q1: holders=483 2020Q2: holders=486 2020Q3: holders=491 2020Q4: holders=502 2021Q1: holders=483 2021Q2: holders=515 2021Q3: holders=488 2021Q4: holders=520 2022Q1: holders=527 2022Q2: holders=532 2022Q3: holders=532 2022Q4: holders=556 2023Q1: holders=552 2023Q2: holders=525 2023Q3: holders=526 2023Q4: holders=557 2024Q1: holders=582 2024Q2: holders=582 2024Q3: holders=590 2024Q4: holders=647 2025Q1: holders=631 2025Q2: holders=655 2025Q3: holders=710 2025Q4: holders=815 2026Q1: holders=804 -105 -52.5 +0 +52.5 +105 399628856 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 11 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 3% -5.9% —
2025Q3 Top 4% -2.3% -6.8%
2025Q2 Top 13% +22.6% +21.3%
2024Q4 Top 8% -10.5% +19.9%
2024Q1 Top 11% +10.8% +32.9%
2023Q4 Top 17% -1.5% +9.1%
2022Q4 Top 16% -18.7% -18.1%
2021Q4 Top 15% +8.2% +8.5%

Options Sentiment

Put holders
10
QoQ: -3
Call holders
15
QoQ: +5

See methodology →

Fundamentals

PE (TTM)
16.2
EPS (TTM)
$7.08
EPS YoY
+3440.0%
Revenue (TTM)
$5.4B
Revenue YoY
+21.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $0.9B 2022-09-30: $0.8B 2022-12-31: $0.9B 2023-03-31: $0.8B 2023-06-30: $1.0B 2023-09-30: $0.9B 2023-12-31: $1.0B 2024-03-31: $0.9B 2024-06-30: $1.0B 2024-09-30: $1.1B 2024-12-31: $1.2B 2025-03-31: $1.1B 2025-06-30: $1.2B 2025-09-30: $1.4B 2025-12-31: $1.5B 2026-03-31: $1.3B 2022-06-30: EPS 0.72 2022-09-30: EPS 0.50 2022-12-31: EPS 0.13 2023-03-31: EPS 0.10 2023-06-30: EPS 0.90 2023-09-30: EPS 0.76 2023-12-31: EPS 0.89 2024-03-31: EPS 0.75 2024-06-30: EPS -2.04 2024-09-30: EPS 0.54 2024-12-31: EPS 0.90 2025-03-31: EPS 0.80 2025-06-30: EPS 2.04 2025-09-30: EPS 2.11 2025-12-31: EPS 1.46 2026-03-31: EPS 1.47 0B 0.8B 1.5B $B -2.24 0.04 2.32 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 29 2023-03-31: PE 44.52023-06-30: PE 39.72023-09-30: PE 28.62023-12-31: PE 21.92024-03-31: PE 17.32024-06-30: PE 172.72024-09-30: PE 541.92024-12-31: PE 469.52025-03-31: PE 316.62025-06-30: PE 20.32025-09-30: PE 17.82025-12-31: PE 15.82026-03-31: PE 13.5 12 291 569 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)